SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-027315
Filing Date
2016-07-05
Accepted
2016-07-05 16:05:44
Documents
1
Period of Report
2016-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3824
  Complete submission text file 0001179110-16-027315.txt   5218
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Issuer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37508 | Film No.: 161750458